Improving Health of Mitochondria May Be a Viable ALS Treatment Option
The amyotrophic lateral sclerosis (ALS) drug Rilutek (riluzole) prevents neuronal cell death in part by acting on mitochondria, suggesting that treatment approaches that target the way mitochondria signal within cells may be a viable approach to treating ALS. The study, “Riluzole But Not Melatonin Ameliorates Acute Motor…